The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | C | Cardiovascular system | |
2 | C05 | Vasoprotectives | |
3 | C05B | Antivaricose therapy | |
4 | C05BB | Sclerosing agents for local injection |
Code | Title | |
---|---|---|
C05BB01 | Monoethanolamine oleate | |
C05BB02 | Polidocanol | |
C05BB03 | Invert sugar | |
C05BB04 | Sodium tetradecyl sulfate | |
C05BB05 | Phenol | |
C05BB56 | Glucose, combinations |
Active Ingredient | Description | |
---|---|---|
Monoethanolamine oleate |
Monoethanolamine oleate is a mild sclerosing agent indicated for the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding. When injected intravenously, monoethanolamine oleate acts primarily by irritation of the intimal endothelium of the vein and produces a sterile dose-related inflammatory response. This results in fibrosis and possible occlusion of the vein. |
|
Phenol |
|
|
Polidocanol |
Polidocanol has a concentration-dependent and volume-dependent damaging effect on the endothelium of blood vessels. |
|
Sodium tetradecyl sulfate |
Sodium tetradecyl sulfate is a sclerosing agent. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent. |
Title | Information Source | Document Type | |
---|---|---|---|
AETHOXYSKLEROL Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
FIBROVEIN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |